X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
mgcd0103 (49) 49
index medicus (40) 40
humans (35) 35
histone deacetylase inhibitors - pharmacology (21) 21
oncology (20) 20
cancer (19) 19
histone deacetylase inhibitor (19) 19
animals (18) 18
apoptosis (16) 16
cell line, tumor (14) 14
histone deacetylase inhibitors (14) 14
histone deacetylases - metabolism (14) 14
antineoplastic agents - pharmacology (13) 13
chemistry, medicinal (13) 13
hdac (12) 12
hematology (12) 12
histone deacetylase (12) 12
phase-i (12) 12
acetylation (11) 11
article (11) 11
benzamides - pharmacology (11) 11
vorinostat (11) 11
female (10) 10
male (10) 10
suberoylanilide hydroxamic acid (10) 10
mice (9) 9
pharmacology & pharmacy (9) 9
structure-activity relationship (9) 9
antineoplastic agents - therapeutic use (8) 8
histone deacetylase inhibitors - therapeutic use (8) 8
hdac inhibitors (7) 7
hemic and lymphatic diseases (7) 7
histone deacetylase inhibitors - chemical synthesis (7) 7
histone deacetylase inhibitors - chemistry (7) 7
hydroxamic acids - pharmacology (7) 7
mocetinostat (7) 7
pyrimidines - pharmacology (7) 7
aged (6) 6
antineoplastic agents - adverse effects (6) 6
antitumor-activity (6) 6
belinostat (6) 6
benzamides - therapeutic use (6) 6
discovery (6) 6
leukemia (6) 6
middle aged (6) 6
panobinostat (6) 6
proteins (6) 6
romidepsin (6) 6
t-cell lymphoma (6) 6
valproic acid (6) 6
acute myeloid-leukemia (5) 5
adult (5) 5
aged, 80 and over (5) 5
antimitotic agents (5) 5
antineoplastic agents (5) 5
antineoplastic agents - chemical synthesis (5) 5
antineoplastic agents - chemistry (5) 5
care and treatment (5) 5
cell biology (5) 5
chemistry, organic (5) 5
chronic lymphocytic leukemia (5) 5
cll (5) 5
dose-response relationship, drug (5) 5
drug administration schedule (5) 5
histone deacetylase inhibitors - adverse effects (5) 5
histones - metabolism (5) 5
leukemia, lymphocytic, chronic, b-cell - genetics (5) 5
lymphoma (5) 5
ms-275 (5) 5
neoplasms - drug therapy (5) 5
original (5) 5
original article (5) 5
potent (5) 5
pyrimidines - therapeutic use (5) 5
research (5) 5
therapy (5) 5
tumors (5) 5
administration, oral (4) 4
analysis (4) 4
antineoplastic agents - administration & dosage (4) 4
benzamides - administration & dosage (4) 4
benzamides - adverse effects (4) 4
benzamides - chemical synthesis (4) 4
benzamides - chemistry (4) 4
cell proliferation (4) 4
combination (4) 4
drug design (4) 4
drug therapy (4) 4
enzyme inhibitors - pharmacology (4) 4
epigenetics (4) 4
gene expression regulation, neoplastic - drug effects (4) 4
hdac inhibitor (4) 4
histone deacetylase inhibitors - administration & dosage (4) 4
histone deacetylase inhibitors - pharmacokinetics (4) 4
in-vitro (4) 4
in-vivo (4) 4
lbh589 (4) 4
molecular structure (4) 4
pyrimidines - administration & dosage (4) 4
pyrimidines - adverse effects (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CNS Neuroscience and Therapeutics, ISSN 1755-5930, 02/2019, Volume 25, Issue 2, pp. 175 - 186
Recently, histone deacetylase (HDAC) inhibitors are considered a possible therapeutic strategy in Alzheimer's disease (AD). However, HDACi treatments exhibit... 
anxiety | MGCD0103 | oligomeric Aβ | cognition | histone deacetylase inhibitor
Journal Article
Journal of Proteome Research, ISSN 1535-3893, 08/2018, Volume 17, Issue 8, pp. 2657 - 2667
Mixed lineage leukemia results from chromosomal rearrangements of the gene mixed lineage leukemia (MLL). MLL-AF9 is one such rearrangement that recruits the... 
LC-MS/MS | MLL-rearranged leukemia | histone modifications | epigenetics | TARGET | H3K79 METHYLATION | MGCD0103 | METHYLTRANSFERASE | DEACETYLASE INHIBITOR | LYSINE | BIOCHEMICAL RESEARCH METHODS | ANTITUMOR-ACTIVITY | DEMETHYLASE | MIXED LINEAGE LEUKEMIA | PROGRAMS
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 13, pp. 1222 - 1228
Journal Article
CNS NEUROSCIENCE & THERAPEUTICS, ISSN 1755-5930, 02/2019, Volume 25, Issue 2, pp. 175 - 186
Aims Recently, histone deacetylase (HDAC) inhibitors are considered a possible therapeutic strategy in Alzheimer's disease (AD). However, HDACi treatments... 
TAU-PROTEIN | MGCD0103 | cognition | PHOSPHORYLATION | ACETYLATION | CONVERSION | ALZHEIMERS-DISEASE | NEURODEGENERATION | MECHANISMS | NEUROSCIENCES | IMPAIRMENT | anxiety | IN-VITRO | MEMORY | histone deacetylase inhibitor | oligomeric A beta(25-35) | PHARMACOLOGY & PHARMACY
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 08/2017, Volume 178, Issue 3, pp. 434 - 441
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 02/2011, Volume 8, Issue 2, pp. 85 - 96
Journal Article
Journal Article